🇺🇸 FDA
Pipeline program

Akkermansia Probiotics

AKPP-I 2025-2-21

Unknown other active

Quick answer

Akkermansia Probiotics for Colo-rectal Cancer is a Unknown program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Colo-rectal Cancer
Phase
Unknown
Modality
other
Status
active

Clinical trials